• Customer Login
  • Search
KindredBio
  • About
    • Background
    • KindredBio Leadership
    • Board of Directors
  • Products
    • Mirataz® (mirtazapine transdermal ointment)
      • Mirataz home
      • About Feline Weight Loss
      • Mechanism of Action
      • Efficacy
      • Safety
      • Dosing and Administration
      • Resources
      • Mirataz News
      • For Cat Owners
      • Frequently Asked Questions
    • Zimeta™ (dipyrone injection)
  • Technology
    • Veterinary Recombinant Biologics
    • Manufacturing Process
  • Pipeline
    • Feline Pipeline
    • Canine Pipeline
    • Equine Pipeline
    • Clinical Trials
  • Education
    • Continuing Education
    • KINections
  • Investors
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Pipeline
      • epoCat™ (feline recombinant erythropoietin)
    • Corporate Governance
    • Stock Information
    • Financial Information
    • Investor Resources
  • News
    • Press Releases
  • Contact Us
    • Contact Us
    • Careers
  • Menu

Archive for: PSD

You are here: Home / PSD

Single Portfolio: 2/3 Slider

Single Portfolio: 2/3 Gallery

KindredBio News

  • Kindred Biosciences Announces Positive Results from Pilot Field Efficacy Study of its IL-4/IL-13 SINK Molecule Being Developed for the Treatment of Atopic Dermatitis in Dogs
  • Kindred Biosciences Announces Mirataz® (mirtazapine transdermal ointment) Transaction and Reports Fourth Quarter and Full Year 2019 Financial Results
  • Event: Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial Results
  • Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial Results
  • Event: Kindred Biosciences to Present at Bank of America Merrill Lynch Animal Health Summit

News Archives

  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • August 2015
  • May 2015
  • March 2015
  • December 2014
  • November 2014
  • August 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • December 2013
  • August 2013
  • July 2013
  • March 2013
  • February 2013
  • January 2013

News

  • Kindred Biosciences Announces Positive Results from Pilot Field Efficacy Study of its IL-4/IL-13 SINK Molecule Being Developed for the Treatment of Atopic Dermatitis in DogsMarch 24, 2020 - 8:33 am
  • Kindred Biosciences Announces Mirataz® (mirtazapine transdermal ointment) Transaction and Reports Fourth Quarter and Full Year 2019 Financial ResultsMarch 16, 2020 - 4:03 pm
  • Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial ResultsMarch 3, 2020 - 4:04 pm

Events

  • Event: Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial ResultsMarch 3, 2020 - 4:05 pm
  • Event: Kindred Biosciences to Present at Bank of America Merrill Lynch Animal Health SummitFebruary 18, 2020 - 8:38 am
  • Event: Kindred Biosciences to Present at Stifel Healthcare ConferenceNovember 14, 2019 - 4:11 pm
$3.98 Stock is No Change 0.00 (0.00%)
KIN (Common Stock)
Previous Close Volume
$3.98 392,401
Intraday High Intraday Low
$4.33 $3.90
52 Week High 52 Week Low
$11.93 $3.10
Exchange: NASDAQ CM

KindredBio proudly supports
Rabies Free Africa

Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements
© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010
Scroll to top